Scientists have uncovered a surprising twist in how bacteria share genes—including those that spread antibiotic resistance.
MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that it ...
BACKGROUND: Genetic variants in components or regulators of the RAS-MAPK signaling pathway are causative for severe and early-onset hypertrophic cardiomyopathy (HCM) in patients with Noonan syndrome ...
Liver fibrosis represents a serious worldwide health issue with a prevalence of around 5% in general populations.1 The most ...
Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in ...
What causes autoimmune disease? A new study finds that somatic mutations in immune checkpoint genes like PDL1 trigger the ...
A new study led by researchers at the Institute of Materials Science of Barcelona (ICMAB-CSIC) reveals why a particular boron ...
Relevance exists between tumorigenesis and embryonic development. Distinct clinical and molecular features, as well as the ...
EM, biochemical, and cell-based assays to examine how Gβγ interacts with and potentiates PLCβ3. The authors present evidence for multiple Gβγ interaction surfaces and argue that Gβγ primarily enhances ...
Mechanosensitive recruitment of DLC1 to focal adhesions creates a positive feedback loop that locally amplifies Rho activation in response to tension.
(Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for ...
A chronic autoimmune condition changes the way you think about your health — and finding a treatment plan that genuinely ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results